← All FR Documents ·← Back to 2024-29086
Notice

Foreign-Trade Zone (FTZ) 61, Notification of Proposed Production Activity; Boehringer Ingelheim Animal Health Puerto Rico LLC; (Animal Health Products); Barceloneta, Puerto Rico

In Plain English

What is this Federal Register notice?

This is a notice published in the Federal Register by Commerce Department, Foreign-Trade Zones Board. Notices communicate information, guidance, or policy interpretations but may not create new binding obligations.

Is this rule final?

This document is classified as a notice. It may or may not create enforceable regulatory obligations depending on its specific content.

Who does this apply to?

Consult the full text of this document for specific applicability provisions. The affected parties depend on the regulatory scope defined within.

When does it take effect?

No specific effective date is indicated. Check the full text for date provisions.

Why it matters: This notice communicates agency policy or guidance regarding applicable regulations.

Document Details

Document Number2024-18175
TypeNotice
PublishedAug 14, 2024
Effective Date-
RIN-
Docket IDB-44-2024
Text FetchedYes

Agencies & CFR References

CFR References:
None

Linked CFR Parts

PartNameAgency
No linked CFR parts

Paired Documents

TypeProposedFinalMethodConf
No paired documents

Related Documents (by RIN/Docket)

Doc #TypeTitlePublished
2024-29086 Notice Foreign-Trade Zone (FTZ) 61; Authorizati... Dec 11, 2024

External Links

📋 Extracted Requirements 0 found

No extractable regulatory requirements found in this document. This is common for documents that:

  • Incorporate requirements by reference (IBR) to external documents
  • Are procedural notices without substantive obligations
  • Contain only preamble/explanation without regulatory text

Full Document Text (314 words · ~2 min read)

Text Preserved
<NOTICE> DEPARTMENT OF COMMERCE <SUBAGY>Foreign-Trade Zones Board</SUBAGY> <DEPDOC>[B-44-2024]</DEPDOC> <SUBJECT>Foreign-Trade Zone (FTZ) 61, Notification of Proposed Production Activity; Boehringer Ingelheim Animal Health Puerto Rico LLC; (Animal Health Products); Barceloneta, Puerto Rico</SUBJECT> Boehringer Ingelheim Animal Health Puerto Rico LLC, submitted a notification of proposed production activity to the FTZ Board (the Board) for its facility in Barceloneta, Puerto Rico within Subzone 61AC. The notification conforming to the requirements of the Board's regulations (15 CFR 400.22) was received on August 8, 2024. Pursuant to 15 CFR 400.14(b), FTZ production activity would be limited to the specific foreign-status material/component and specific finished product described in the submitted notification (summarized below) and subsequently authorized by the Board. The benefits that may stem from conducting production activity under FTZ procedures are explained in the background section of the Board's website—accessible via <E T="03">www.trade.gov/ftz.</E> The proposed finished product and material/component would be added to the production authority that the Board previously approved for the operation, as reflected on the Board's website. The proposed finished product is finished/packaged heartworm treatment chewable tablets for canines (duty-free). The proposed foreign-status material/component is moxidectin (duty rate of 3.7%). The request indicates that the material/component is subject to duties under section 301 of the Trade Act of 1974 (section 301), depending on the country of origin. The applicable section 301 decisions require subject merchandise to be admitted to FTZs in privileged foreign status (19 CFR 146.41). Public comment is invited from interested parties. Submissions shall be addressed to the Board's Executive Secretary and sent to: <E T="03">ftz@trade.gov.</E> The closing period for their receipt is September 23, 2024. A copy of the notification will be available for public inspection in the “Online FTZ Information System” section of the Board's website. For further information, contact Kolade Osho at <E T="03">Kolade.Osho@trade.gov.</E> <SIG> <DATED>Dated: August 8, 2024.</DATED> <NAME>Elizabeth Whiteman,</NAME> Executive Secretary. </SIG> <FRDOC>[FR Doc. 2024-18175 Filed 8-13-24; 8:45 am]</FRDOC> </NOTICE>
This text is preserved for citation and comparison.